Glutaminyl Cyclase, Diseases, and Development of Glutaminyl
Por um escritor misterioso
Descrição
IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes
PDF) Preparation of imidazolyl thiourea derivs. as glutaminyl cyclase inhibitors for treating cancer, nervous system disorders, and other diseases
A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies
Glutaminyl cyclase inhibition leads to reduced binding of recombinant
Increased glutaminyl cyclase activity in brains of Alzheimer's disease individuals - Gunn - 2021 - Journal of Neurochemistry - Wiley Online Library
IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes
Human glutaminyl cyclase: Structure, function, inhibitors and involvement in Alzheimer's disease - ScienceDirect
Glutaminyl Cyclase Inhibitor PQ912 Improves Cognition in Mouse Models of Alzheimer's Disease—Studies on Relation to Effective Target Occupancy
Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors
Inhibitors for Human Glutaminyl Cyclase by Structure Based Design and Bioisosteric Replacement
Discovery of potential scaffolds for glutaminyl cyclase inhibitors: virtual screening, synthesis, and evaluation - ScienceDirect
Frontiers Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease
IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes
Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer's Agents by Structure-Based Design
de
por adulto (o preço varia de acordo com o tamanho do grupo)
